These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 1714518

  • 1. Characterization of monoclonal antibodies against the human immunodeficiency virus matrix protein, p17gag: identification of epitopes exposed at the surfaces of infected cells.
    Shang F, Huang H, Revesz K, Chen HC, Herz R, Pinter A.
    J Virol; 1991 Sep; 65(9):4798-804. PubMed ID: 1714518
    [Abstract] [Full Text] [Related]

  • 2. Characterization of murine monoclonal antibodies directed against the submembrane protein p17 of HIV-1.
    Niedrig M, Harthus HP, Bröker M, Meloen R, Gelderblom H, Pauli G.
    Hybridoma; 1993 Aug; 12(4):431-9. PubMed ID: 7503941
    [Abstract] [Full Text] [Related]

  • 3. Three antigenic regions in p17 of human immunodeficiency virus type 1 (HIV-1) revealed by mouse monoclonal antibodies and human antibodies in HIV-1 carrier sera.
    Liu X, Ota A, Watanabe M, Ueda S, Saitoh A, Shinagawa H, Nakata A, Kurimura T, Wang X, Zhao Y.
    Microbiol Immunol; 1995 Aug; 39(10):775-85. PubMed ID: 8577268
    [Abstract] [Full Text] [Related]

  • 4. Epitope mapping of monoclonal antibodies against human immunodeficiency virus type 1 structural proteins by using peptides.
    Niedrig M, Hinkula J, Weigelt W, L'age-Stehr J, Pauli G, Rosen J, Wahren B.
    J Virol; 1989 Aug; 63(8):3525-8. PubMed ID: 2473220
    [Abstract] [Full Text] [Related]

  • 5. Human immunodeficiency virus type 1-neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping.
    Papsidero LD, Sheu M, Ruscetti FW.
    J Virol; 1989 Jan; 63(1):267-72. PubMed ID: 2462060
    [Abstract] [Full Text] [Related]

  • 6. Characterization of murine monoclonal antibodies directed against the core proteins of human immunodeficiency virus types 1 and 2.
    Niedrig M, Hinkula J, Harthus HP, Bröker M, Hopp L, Pauli G, Wahren B.
    J Virol; 1991 Aug; 65(8):4529-33. PubMed ID: 1712863
    [Abstract] [Full Text] [Related]

  • 7. Cross-reactivity of anti-HIV-1-p17-derivative peptide (P30-52) antibody to Env V3 peptide.
    Ota A, Tanaka-Taya K, Ueda S.
    Hybridoma; 1999 Apr; 18(2):149-57. PubMed ID: 10380014
    [Abstract] [Full Text] [Related]

  • 8. A peptide library expressed in yeast reveals new major epitopes from human immunodeficiency virus type 1.
    Madaule P, Gairin JE, Bénichou S, Rossier J.
    FEMS Microbiol Immunol; 1991 Apr; 3(2):99-107. PubMed ID: 1713777
    [Abstract] [Full Text] [Related]

  • 9. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J, Salvetti JL, Beltramini LM, Tonarelli G.
    Rev Argent Microbiol; 2004 Apr; 36(4):151-7. PubMed ID: 15786866
    [Abstract] [Full Text] [Related]

  • 10. Characterization of antibodies reacting with HIV gag proteins occasionally found in the serum of non-infected subjects.
    Bürgisser P, Frei PC.
    Clin Exp Immunol; 1991 Aug; 85(2):219-23. PubMed ID: 1713811
    [Abstract] [Full Text] [Related]

  • 11. Immunodominant epitopes of HIV-1 p17 and p24.
    Graham S, Follett EA, Wallace L, Desselberger U, Marsden HS.
    AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1781-8. PubMed ID: 1280955
    [Abstract] [Full Text] [Related]

  • 12. Random expression of human immunodeficiency virus-1 (HIV-1) p17 (epitopes) on the surface of the HIV-1-infected cell.
    Ota A, Liu X, Fujio H, Sakato N, Ueda S.
    Hybridoma; 1998 Feb; 17(1):73-5. PubMed ID: 9523241
    [Abstract] [Full Text] [Related]

  • 13. Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study.
    O'Toole CM, Lowdell MW, Chargelegue D, Colvin BT.
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1361-8. PubMed ID: 1281655
    [Abstract] [Full Text] [Related]

  • 14. Identification of regions of HIV-1 p24 reactive with sera which give "indeterminate" results in electrophoretic immunoblots with the help of long synthetic peptides.
    Blomberg J, Vincic E, Jönsson C, Medstrand P, Pipkorn R.
    AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1363-72. PubMed ID: 2127683
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of antibodies to the core protein P17, a serological marker during HIV-1 infection.
    Mehta SU, Rupprecht KR, Hunt JC, Kramer DE, McRae BJ, Allen RG, Dawson GJ, Devare SG.
    AIDS Res Hum Retroviruses; 1990 Apr; 6(4):443-54. PubMed ID: 1692727
    [Abstract] [Full Text] [Related]

  • 16. Epitope mapping of a monoclonal antibody which binds HIV-1 Gag and not the Gag-derived proteins.
    Sarubbi E, Denaro M.
    FEBS Lett; 1993 Dec 13; 335(3):335-7. PubMed ID: 7505237
    [Abstract] [Full Text] [Related]

  • 17. Multiple antigenic epitopes expressed on gag proteins, p26 and p15, of a human immunodeficiency virus (HIV) type 2 as defined with a library of monoclonal antibodies.
    Komatsu H, Tozawa H, Kawamura M, Kodama T, Hayami M.
    AIDS Res Hum Retroviruses; 1990 Jul 13; 6(7):871-81. PubMed ID: 1697178
    [Abstract] [Full Text] [Related]

  • 18. Neutralization of human immunodeficiency virus type 1 (HIV-1) with antibody from carriers' plasma against HIV-1 protein p17.
    Kageyama S, Katsumoto T, Taniguchi K, Ismail SI, Shimmen T, Sasao F, Gao M, Owatari S, Wakamiya N, Tsuchie H, Ueda S, Shiraki K, Kurimura T.
    Acta Virol; 1996 Sep 13; 40(4):195-200. PubMed ID: 9014009
    [Abstract] [Full Text] [Related]

  • 19. A neutralizing monoclonal antibody previously mapped exclusively on human immunodeficiency virus type 1 gp41 recognizes an epitope in p17 sharing the core sequence IEEE.
    Buratti E, Tisminetzky SG, D'Agaro P, Baralle FE.
    J Virol; 1997 Mar 13; 71(3):2457-62. PubMed ID: 9032383
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and persistence of antibody titers to recombinant HIV-1 core and matrix proteins in HIV-1 infection.
    Janvier B, Mallet F, Cheynet V, Dalbon P, Vernet G, Besnier JM, Choutet P, Goudeau A, Mandrand B, Barin F.
    J Acquir Immune Defic Syndr (1988); 1993 Aug 13; 6(8):898-903. PubMed ID: 8315575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.